Tag: Financial Results
F&P fields questions on mask pipeline, tariff impact
May 27, 2026Liz Beaulieu, Editor
AUCKLAND, New Zealand – Analysts pressed Fisher & Paykel Healthcare executives during a recent earnings call on the company’s lack of new full-face mask launches for obstructive sleep apnea (OSA), even as other product categories continue to gain traction.
Analyst Ben Crozier described the full-face mask category as “a bit of a headwind” for F&P, noting it has been offset by more recent and frequent launches in other categories, including the F&P Solo (nasal), F&P Nova...
F&P sees high, single-digit boost from recent mask launches
May 26, 2026HME News Staff
AUCKLAND, New Zealand – Fisher & Paykel Healthcare reported revenue of $802.7 million for the 2026 financial year for its Homecare product group, an 8% increased compared to the previous year.
Revenue from obstructive sleep apnea (OSA) masks was up 7%.
“Our latest mask ranges, the F&P Solo and F&P Nova, continued to drive OSA mask growth,” said Lewis Gradon, managing director and CEO. “Our newest offering, the F&P Nova Nasal, was launched in the United...
Accendra Health reports Q1, announces $1.5B optimization
May 11, 2026HME News Staff
RICHMOND, Va. – Accendra Health reported $627.8 million for the first quarter of 2026 vs. $673.9 million for the same period last year. Adjusted EBITDA was $58.4 million vs. $96 million.
Unless otherwise noted, the results reflect Accendra’s continuing operations, which represent what was previously the Patient Direct segment and certain functional operations. The company ended the fourth quarter of 2025 by selling its Products & Healthcare Services (P&HS) business to Platinum...
McKesson says it is well-positioned going into 2027
May 11, 2026HME News Staff
IRVING, Texas – McKesson Corp. has reported consolidated revenues of $96.3 billion for the fourth quarter of fiscal year 2026, a 6% increase. It reported revenues of $403.4 billion for the full year, a 12% increase.
Fourth quarter highlights:
Earnings per diluted share of $13.71 increased $3.70.
Adjusted Earnings per diluted share of $11.69 increased 16%.
McKesson entered into a $2.25 billion accelerated share repurchase program.
McKesson’s board of directors approved a...
Medline positions for sustained growth
May 11, 2026HME News Staff
NORTHFIELD, Ill. – Medline reported net sales of $7.4 billion for the first quarter of 2026, a 10.7% increase. Net income was $239 million, a 25.8% decrease.
Other financial results:
Adjusted EBITDA of $776 million, a decrease of 10.6%.
Diluted earnings per share and adjusted diluted EPS were $0.16 and $0.33, respectively.
Net cash provided by operating activities in the first quarter 2026 was $412 million, driven by net income, excluding the impact of non-cash items, partially...
Resmed cites momentum, continued progress in Q3
April 30, 2026HME News Staff
SAN DIEGO – Resmed reported revenue increased by 11% to $1.4 billion for the third quarter fiscal year 2026.
Other financial results:
GAAP gross margin up 290 bps to 62.2%; non-GAAP gross margin up 290 bps to 62.8%
GAAP income from operations increased 17%; non-GAAP income from operations up 18%
GAAP diluted earnings per share of $2.74; non-GAAP diluted earnings per share of $2.86
Operating cash...
Cardinal Health raises profit growth for Other segment
April 30, 2026HME News Staff
DUBLIN, Ohio – Cardinal Health’s Other segment saw a 31% increase in revenue in the third quarter of fiscal year 2026 to $1.7 billion, driven by growth across the three operating segments, including at-Home Solutions. The company now expects the segment to see profit growth of 36% to 38% for the year.
Other financial results
Overall revenue increased 11% to $60.9 billion.
Third quarter GAAP operating earnings decreased 30% to $509 million and GAAP diluted earnings per share...
InfuSystem ‘makes advances,’ building on tech investments
February 24, 2026HME News Staff
ROCHESTER HILLS, Mich. - InfuSystem Holdings reported revenue of $36.2 million for the fourth quarter and $143.4 million for the full year ended Dec. 31, 2025, increases of 7% and 6%, respectively, compared to the prior year. Patient Services net revenue was $21.9 million for the quarter, and Device Solutions net revenue was $14.4 million for the quarter. For the full year, Patient Services revenue $86.5 million and Device Solutions was $86.9 million. "During the fourth quarter we continued...
McKesson reports flat revenues for Medical-Surgical segment
February 9, 2026HME News Staff
IRVING, Texas – McKesson has reported $3 billion in revenues for the third quarter of fiscal year 2026 for its Medical-Surgical Solutions segment, a 1% increase, driven by higher volumes of specialty pharmaceuticals.
For the segment, operating profit was $265 million, and adjusted segment operating profit was $265 million, a 10% decrease, driven by lower volumes across physician office settings and lower incidence of illness for the season.
McKesson reported $106.2...
Cardinal’s at-Home Solutions helps to push double-digit growth
February 5, 2026HME News Staff
DUBLIN, Ohio – Cardinal Health has reported that revenue for its Other segment, which includes at-Home Solutions, increased 34% to $1.7 billion for its second quarter fiscal year 2026. Profit for the Other segment increased 52% to $179 million.
Overall, Cardinal Health reported revenue increased 19% to $65.6 billion.
“Our strong second-quarter performance reflects at least double-digit segment profit growth across all five of our operating...